Earnings per Share (EPS) of $3.09 missed the estimated $3.47, yet revenue exceeded expectations at $2.38 billion.
The company boasts a Price-to-Earnings (P/E) ratio of 4.22 and a Price-to-Sales ratio of 0.59, indicating a low valuation and attractiveness to value investors.
Zacks Rank of #1 (Strong Buy) reflects a positive analyst outlook based on ASHTY’s financial health and market position.
Ashtead Group PLC, trading under the symbol ASHTY on the PNK exchange, is a prominent player in the industrial services sector. The company provides equipment rental services, primarily in the United States and the United Kingdom. It competes with firms like W.W. Grainger, which also operates in the industrial services space.
On March 4, 2025, ASHTY reported earnings per share (EPS) of $3.09, which was below the estimated $3.47. Despite this, the company exceeded revenue expectations, generating $2.38 billion compared to the estimated $2.13 billion. This indicates strong sales performance, even if profitability was slightly below expectations.
ASHTY’s financial metrics suggest a strong value proposition. The company has a price-to-earnings (P/E) ratio of 4.22, indicating a low valuation relative to its earnings. Its price-to-sales ratio of 0.59 suggests the stock is trading at a low price compared to its sales, making it attractive to value investors.
The enterprise value to sales ratio of 1.59 and the enterprise value to operating cash flow ratio of 11.04 provide further insight into ASHTY’s valuation. These figures suggest the company is valued reasonably in relation to its revenue and cash flow from operations, highlighting its financial stability.
ASHTY’s earnings yield of 23.69% indicates a strong return on investment for shareholders. With a debt-to-equity ratio of 1.46, the company maintains a moderate level of debt, while a current ratio of 1.31 suggests it has sufficient liquidity to cover short-term liabilities. This financial health is reflected in its Zacks Rank of #1 (Strong Buy), as highlighted by Zacks Investment Research, indicating a positive analyst outlook.
